October 2025

Deadline
10/7/2025

Award Amount
$700,000

Target Audience/Eligibility
Candidates must hold an M.D., D.D.S., D.V.M., or

D.O. degree; Candidates must not be more than 13 years past their clinical doctorate degree; Candidates may hold a junior faculty appointment

Deadline
10/31/2025

Award Amount
$100,000

Target Audience/Eligibility
Institutions must have public charity status/nonprofit status under IRS Code Section 501(c)(3) or a Charitable Designation Number, if in Canada.

Programs must target education and/or care of women.

The Heart to Heart Grant now has two arms of eligibility for two different grants, Clinical and Community:

Clinical: projects that are traditional bench/clinical research. These projects may be from hospitals, universities/schools, or research programs. The Heart to Heart Clinical Grant is $100,000.

Community: projects more focused on community engagement, education, and programming as opposed to research. These proposals may come from hospitals, universities/schools, or community organizations. The Heart to Heart Community Grant is up to $25,000.

Deadline
10/16/2025

Award Amount
Varies

Target Audience/Eligibility
PhDs and/or MDs who are current residents, fellows in training or have completed training within the last 5 years, or other doctoral prepared professionals who are early in their career development and have interest in cardiovascular or stroke research.

Get With The Guidelines® (GWTG) is a hospital-based quality improvement program designed to close the treatment gap in cardiovascular disease, stroke, and resuscitation. It includes modules in atrial fibrillation, coronary artery disease, heart failure, resuscitation and stroke.

Deadline
10/31/2025

Award Amount
$100,000

Target Audience/Eligibility
Faculty appointment, postdocs can not apply. Young/non-tenured Investigators are allowed to budget up 75% of the total grant amount as PI salary.

Organization
PHRMA Foundation

Specialty Area
Clinical Outcomes; Evaluation/ Quality

Award/Grant Name
Value Assessment and Health Outcomes Research

Faculty Starter Grant

Deadline
10/30/2025

Award Amount
$100,000

Target Audience/Eligibility
Applicants (U.S. and non-U.S. citizens) must be full-time, promotion-eligible, research-intensive faculty at a doctoral degree-granting accredited U.S. university at the time of application submission.

You are not eligible if your faculty status began before January 1, 2023.

Applicants who have taken a formal leave of absence from their career (e.g., parenting of a child, childbirth, long-term care of a parent/spouse/child/dependent, personal health issues) that puts them outside of the eligibility time frame can reach out to PhRMA Foundation staff ahead of their application submission to determine their eligibility. The Foundation requires confirmation from the school that such leave was formally taken.

Applicants must be eligible to apply for independent external research funding by their university.

Applicants should not have other substantial sources of research funding, excluding intramural funding or start-up funding from their university. Applicants are ineligible if they are the principal investigator (PI) of an R or K series award from the National Institutes of Health (NIH), a CAREER award from the National Science Foundation, or other significant financial award from any grant-making institution. Generally, funding over $150,000 a year is considered substantial, unless you are the PI of a grant where funds go to training others. If this is the case, explain in your extended letter.

The Foundation will not consider multiple applications for the same or similar efforts on the same project. If multiple applicants are submitting proposed efforts on the same project, the efforts must be separate activities and not duplicative. This pertains to applications in all categories of our VA-HOR program (predoctoral/postdoctoral fellowships and faculty starter grants).

The PhRMA Foundation seeks research proposals that investigate challenges and potential solutions related to evaluating the delivery, safe use, effectiveness, and value (clinical, patient-centered, and economic) of medicines and other health care interventions. Proposals could be empirical analyses or studies addressing methodological aspects of the following areas:

• Clinical outcomes assessments
• Patient-reported and/or patient-centered outcomes
• Patient health preferences research
• Clinical and economic outcomes using real-world data and analytic tools
• Evaluation and outcomes assessments focused on health equity or unmet need
• Innovative methods for measuring and reporting novel value elements (e.g., clinical, cost, health preference) from different stakeholder perspectives, especially patients
• Development of innovative decision and communication tools
• Patient-centered value assessment frameworks
• Empirical health policy research
• Proposals should incorporate patient engagement at an appropriate level to be considered responsive. A responsive application is one that has already incorporated or will incorporate “active, meaningful, and collaborative interaction between patients and researchers.”

Proposals that do not engage patients, caregivers, or clinicians will be considered unresponsive.

Deadline
10/31/2025

Award Amount
Varies

Target Audience/Eligibility
Graduates of medical and graduate schools in the biological sciences holding MD or PhD; Individuals who have held a Ph.D or M.D. degree for more than 5 years at the time of application are not eligible for a fellowship. Must have begun (or will begin) working in your proposed postdoc lab between August 1, 2023 and July 31, 2025.

Organization
American Association for the Study of Liver Diseases

Specialty Area
Liver Disease

Award/Grant Name
Bridge Award in Liver Diseases

Deadline
10/15/2025

Award Amount
$100,000 

Target Audience/Eligibility
In order to be eligible for this award, the applicant must adhere to the following guidelines:

The applicant must:

• Have a faculty appointment at or below the rank of Associate Professor.
• Be a member of the American Association for the Study of Liver Diseases (AASLD) at the time of award application and maintain active membership for the duration of the award period.
• Be able to devote at least 20% effort to the research project on which this application is based.
• Be sponsored by a public or private non-profit institution accredited in the United States, Canada or Mexico engaged in health care and health-related research. Individuals employed at the NIH, FDA, and CDC are not eligible to apply.
• Have submitted their highly scored NIH R or other federal equivalent application within the last 18 months as of the application deadline (eligibility window starts on the date your application was reviewed by the NIH/federal equivalent study section). The applicant must be able to provide their Summary Statements and their submitted award materials on Standard Forms SF424 (R&R).
• Not currently hold a federally funded non-mentored grant (e.g., R01, P01, VA Merit) and not hold such a grant during the award period.
• Not hold other significant extramural mentored or non-mentored research funding (greater than $50,000) during the award period. Institutional funding and/or pilot research funding may be held during the award term. 

Deadline
10/21/2025

Award Amount
$40,000

Target Audience/Eligibility
Achievement of impactful advancement in the understanding of and/or treatment of multiple sclerosis; must be actively engaged in basic or clinical research related to multiple sclerosis. Applicants do not need to be an AAN member to apply. Industry employees are not eligible to apply.

The prize recognizes significant and exciting work that has changed the way we think about multiple sclerosis. Only accomplishments directly related to multiple sclerosis will be considered; advances in other central nervous system inflammatory diseases will be considered only insofar as they advance the understanding of multiple sclerosis. While service to and leadership of the multiple sclerosis community will be considered, innovative research with lasting impact on the understanding of and/or treatment of multiple sclerosis is the primary criterion for selection. Recent and ongoing active research is a major consideration; the Dystel Prize is not meant to be a lifetime achievement award.

Deadline
10/22/2025 (LOI)

Award Amount
$140-160,000 over 2 years

Target Audience/Eligibility
The applicant must be within five years of receiving his or her PhD at the time the award starts and must name an individual who will serve as his or her research mentor and supervisor. 

Research proposals from promising early-career scientists that will directly impact the understanding of Parkinson’s disease or its treatment.

Deadline
10/29/25 (LOI)

Award Amount
$400,000 over 4 years

Target Audience/Eligibility
Applicant must possess a PhD, MD, or equivalent degree and be within 18 months to 6 years of completing that degree or clinical training at the time of application, including resubmission. Applicant must currently be in a postdoctoral or other mentored position and must name and provide a letter of support from an established investigator who will serve as the mentor and supervisor. Applicants requiring less than 12 months of mentored research training and career development are not eligible for this award. Applicants may not have their own lab or equivalent. US citizenship or permanent resident status are not required.

Deadline
10/10/25 (LOI)

Award Amount
$200,000 over 2 years

Target Audience/Eligibility
This award is open to scientists with a PhD or MD, regardless of nationality or location. The Parkinson's Foundation Impact Awards are intended for researchers both established and new to the field of PD.

Only independent investigators are eligible to serve as PIs - applicants must hold a tenure-track position or equivalent. Non-tenure track faculty may serve as Co-PIs, and postdoctoral fellows are eligible to serve as Co-Is. Applications from Instructors will be considered if they can demonstrate that they will begin a tenure-track position by the award start date (as confirmed by a support letter from their department chair). The Foundation reserves the sole authority to determine an applicant’s eligibility. Awardees may not concurrently hold an award from another source with overlapping specific aims.

The Parkinson's Foundation Impact Awards support innovative projects from their inception, providing the necessary resources to maximize their impact on the Parkinson's community. The science underlying the Parkinson's Foundation Impact Award projects should be "outside the box" with the goal of bringing new light to the biology of Parkinson’s disease (PD), a new approach to PD research, or testing a truly novel therapeutic idea. Projects should be based on groundbreaking or unconventional ideas that are unlikely to be funded through more traditional funding mechanisms. Both established researchers and newcomers to PD research are encouraged to apply.

Deadline
10/1/2025 (LOI)

Award Amount
Up to $75,000

Target Audience/Eligibility
Established scientists of all ages.

The foundation is currently interested in invertebrate and vertebrate (excluding clinical) neurobiology, specifically investigations of neural mechanisms involved in sensory, motor, and other complex functions of the whole organism as these relate to behavior. The overall goal should be to better understand behavioral output or brain mechanisms of behavior.

Deadline
10/1/2025 (LOI)

Award Amount
$30,000

Target Audience/Eligibility
Designed for researchers at Assistant Professor level who experience difficulty competing for funds because they have not yet become firmly established; can also be made to senior scientists who are taking a new direction with research.

The foundation is currently interested in invertebrate and vertebrate (excluding clinical) neurobiology, specifically investigations of neural mechanisms involved in sensory, motor, and other complex functions of the whole organism as these relate to behavior. The overall goal should be to better understand behavioral output or brain mechanisms of behavior.

Deadline
10/25/2025

Award Amount
$50,000 

Target Audience/Eligibility
Principal investigators must hold an earned master's degree or have completed candidacy requirements in a BSN-to-PhD or DNP program; current AACN membership required.

Deadline
10/25/2025

Award Amount
$10,000 

Target Audience/Eligibility
Available to AACN and Sigma Theta Tau members.

Deadline
10/3/2025

Award Amount
$300,000 over 1-2 years

Target Audience/Eligibility
Independent Investigator.

• Outcome studies related to nursing regulation;
• Nursing workforce;
• Substance use disorders in nursing;
• New technologies related to the profession; 
• Practice innovations/new models of care delivery LPN, RN and APRN scope of practice;
• Impact of policy on nursing.

Deadline
10/1/25

Award Amount
$250,000

Target Audience/Eligibility
The following may apply: medical, nursing, allied health, and/or pharmacy professional schools; healthcare
institutions (both large and small); professional organizations/medical societies; medical education
companies; and other entities with a mission related to healthcare professional education and/or healthcare
improvement.

• Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an
  independent group of physicians not affiliated with a hospital, academic institution, or professional society).
• If the project involves multiple departments within an institution and/or between different institutions /
  organizations / associations, all institutions must have a relevant role and the requesting organization must
  have a key role in the project.
• The applicant must be the project/program lead or an authorized designee of such individual (e.g., project/program lead’s grant coordinator).

It is not our intent to support clinical research projects. Projects evaluating the efficacy of therapeutic or diagnostic agents will not be considered. Advanced Practice Providers (APPs) play an important role in the care of people with cancer, acting as an extension of the medical oncologist workforce in an often resource constrained environment. Projects that will be considered for Pfizer support will focus on strengthening the knowledge and skills of APPs and other healthcare providers in the following areas:

• Understanding guideline concordant biomarker and genetic testing practices, including the
  role of germline and somatic mutations or alterations in the context of cancer care
• Best practices for clinical care pathways for routine and rapid testing in tumor types with actionable
  biomarkers such as lung, colorectal cancer, and prostate cancer.
• Interpreting the results of comprehensive molecular profiling reports
• Discussing the clinical implications, implementation and applicability of biomarker and genetic testing results with patients and their caregivers

Deadline
10/1/25

Award Amount
$250,000

Target Audience/Eligibility
Only organizations are eligible to receive grants, not individuals or physician-owned medical practices or individual-physician-owned organizations.

• If the project involves multiple departments within an institution and/or between different institutions / organizations / associations, all institutions must have a relevant role and the requesting organization must have a key role in the project.
• The applicant must be the project/program lead or an authorized designee of such individual (e.g., project/program lead’s grant coordinator).

With new trials further investigating treatment optimization in the first-line maintenance setting and the evolving MBC therapeutic landscape, understanding the role and value of maintenance therapy is critical for making informed treatment decisions.

Independent education projects should improve understanding and knowledge of:

• the role of maintenance therapy in the 1L HER2+ MBC setting, including the current standard of care approach introduced by CLEOPATRA
• maintenance therapy considerations with endocrine therapy for HR+/HER2+ MBC patients
• combinations in the 1L HER2+ MBC maintenance setting, including differentiation of therapy by HR status
• overall treatment paradigm and evolving first-line standard of care options for patients with HER2+ MBC based on latest clinical data updates
• safety profiles of available therapies and how they affect:
  • Adverse event management, including early identification and appropriate mitigation strategies
  • Sequencing of available therapies
  • Re-treatment algorithms

Examples of educational formats that will be considered under this RFP include but are not limited to:

• On-agenda educational sessions during live conferences
• Symposia or symposia series alongside major congresses such as SABCS, ASCO etc.
• Grand Rounds – single events or series – online or in-person
• Peer-to-peer education
• Online articles, newsletter articles, training courses, webinars
• Videos, podcasts, infographics, animations

The Clinical Investigator Award promotes patient-focused research conducted by surgical oncologists in clinical and translational science. 

Deadline
10/1/2025

Award Amount
$100,000 

Target Audience/Eligibility
Senior-level investigators; ARVO members; record of successfully mentoring clinician-scientists to independent academic and research careers.

Deadline
10/30/2025

Award Amount
$150,000 over 2 years

Target Audience/Eligibility
Candidates must hold an MD, PhD, DVM, DO, OD or equivalent degree

Postdoctoral fellows are eligible to apply as Co-Principal Investigator for the Standard Award.

Applicant must serve as the Principal Investigator on the project and have independent laboratory space. The applicant should use the indicated space on the application forms to clarify any position that is not immediately recognizable as an independent research position.

National Glaucoma Research, a BrightFocus Foundation program, provides research funds for U.S. domestic and international researchers pursuing pioneering research leading to greater understanding, prevention, and treatment of glaucoma.

We are committed to supporting scientists from diverse backgrounds to foster creativity and innovation in addressing complex scientific challenges and strongly encourage applications from individuals who are from groups underrepresented in glaucoma research.

Deadline
10/16/2025 (LOI)

Award Amount
$100,000

Target Audience/Eligibility
These opportunities seek candidates that hold a Ph.D., M.D., M.D./Ph.D., D.M.D., D.V.M., D.O., O.D., or equivalent degree and have a faculty position or equivalent at a domestic or foreign: non-profit organization, or public or private institution, such as a university, college, medical school, hospital, research institute, or laboratory. Individuals from underrepresented racial, ethnic and gender groups, as well as individuals with disabilities, are always encouraged to apply.

Deadline
10/29/2025 (LOI)

Award Amount
Up to $2 million

Target Audience/Eligibility
Researchers in a range of career stages.

Deadline
10/20/2025 (LOI)

Award Amount
$250,000 

Target Audience/Eligibility
Individuals with the following education and training are eligible to apply: Master’s level degree or higher.

Organization
Francis Families Foundation

Specialty Area
Pulmonology, Sleep Medicine, Critical Care/EM

Award/Grant Name
Parker B. Francis Fellowship Program 

Deadline
10/10/2025

Award Amount
$225,000 over 3 years

Target Audience/Eligibility
A Ph.D. or other non-M.D. scientist no more than seven years beyond completion of their doctoral degree or an M.D. scientist no more than seven years beyond clinical training (i.e., residency, internship, clinical fellowship) at the time of application.

Organization
Society of Toxicology

Specialty Area
Toxicology

Award/Grant Name
Colgate-Palmolive Postdoctoral Fellowship Award in In Vitro Toxicology

Deadline
10/9/2025

Award Amount
$44,000 

Target Audience/Eligibility
Postdoctoral trainees in their first year of study beyond the PhD, MD, or DVM degree who are at academic institutions, federal/national laboratories, or research institutes worldwide may apply.